SCHEMBL10111041

SCHEMBL10111041

COCCOCCOCCOc1cc(C)ccc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.54
L3MBTL1 Q9Y468 5/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
MAPT P10636 5/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 4/20 0.49
LMNA P02545 3/20 0.48
MAPK1 P28482 2/20 0.48
TDP1 Q9NUW8 4/20 0.48
CYP2C9 P11712 2/20 0.48
TTR P02766 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C8 P10632 1/20 0.48
CHRM1 P11229 1/20 0.48
ADRA1A P35348 1/20 0.48
PPARG P37231 1/20 0.48
HTR2B P41595 1/20 0.48
PPARA Q07869 1/20 0.48
SLCO1B3 Q9NPD5 1/20 0.48
CISD1 Q9NZ45 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18644135 1.00 TSHR (0.54) TSHRL3MBTL1SMN1; SMN2MAPTKDM4E
SCHEMBL13475556 0.94 TSHR (0.59) TSHRL3MBTL1SMN1; SMN2MAPTKDM4E
SCHEMBL17124806 0.88 TSHR (0.57) TSHRL3MBTL1SMN1; SMN2KDM4EALDH1A1
SCHEMBL13933168 0.87 L3MBTL1 (0.59) L3MBTL1SMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL19708262 0.87 L3MBTL1 (0.59) L3MBTL1SMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL5929495 0.87 TSHR (0.67) TSHRL3MBTL1SMN1; SMN2MAPTKDM4E
SCHEMBL19473410 0.86 L3MBTL1 (0.57) TSHRL3MBTL1SMN1; SMN2MAPTKDM4E
SCHEMBL15430848 0.86 HTR1A (0.57) TSHRL3MBTL1SMN1; SMN2MAPTKDM4E
SCHEMBL89387 0.85 TSHR (0.62) TSHRL3MBTL1SMN1; SMN2MAPTKDM4E
SCHEMBL10111043 0.84 TSHR (0.57) TSHRL3MBTL1SMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9758688-B2 Composition for forming conductive film SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-09-12 US disclosed
US-9704612-B2 Composition of silver-conjugated compound composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-11 US disclosed
US-9601696-B2 Electroluminescent composition and electric device with high brightness SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-03-21 US disclosed
US-9536633-B2 Metallic composite and composition thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-01-03 US disclosed
US-9412487-B2 Silver-(conjugated compound) composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-08-09 US disclosed
US-20150275015-A1 COMPOSITION FOR FORMING CONDUCTIVE FILM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-10-01 US disclosed
US-8866134-B2 Light-emitting device and photovoltaic cell, and method for manufacturing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-10-21 US disclosed
US-20130099224-A1 LIGHT-EMITTING DEVICE AND PHOTOVOLTAIC CELL, AND METHOD FOR MANUFACTURING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-25 US disclosed
US-20120168693-A1 SILVER-(CONJUGATED COMPOUND) COMPOSITE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-05 US disclosed
US-20120032121-A1 METALLIC COMPOSITE AND COMPOSITION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120032121-A1 METALLIC COMPOSITE AND COMPOSITION THEREOF CDH1, EPCAM, CD4 TSHR 3714/4885L3MBTL1 3707/4885SMN1; SMN2 2087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.